Subscribe to Updates
Get the latest creative news from FooBar about art, design and business.
Browsing: Pharma
Earlier this year, when the FDA asked Amgen to pull its rare disease drug Tabneos…
As the decision on the next-generation CAR-T approaches, Kite prepares to make full-scale efforts based on “lessons learned”
By healthadmin
After recalibrating its production strategy in the late 2010s to better align with the realities…
AstraZeneca’s three-in-one inhaler Breztri Aerosphere has passed another significant milestone, inching towards the British drugmaker’s…
Haleon has launched a soccer-focused marketing campaign ahead of the FIFA World Cup in the…
Novartis sticks to $5 billion Pluvicto target despite European regulatory setbacks and bispecific competition
By healthadmin
Novartis CEO Basu Narasimhan is doubling down on Pluvicto’s $5 billion peak sales forecast, even…
GSK’s Tesaro unit has dealt a blow to its legal battle with Jemperli developer AnaptysBio,…
Mundipharma and CorMedix announce the victory of the antifungal drug Rezzayo in preventing invasive fungal…
Xtandi’s days of growth are numbered, and an unflinching Astellas expects a series of new…
Clinical trials are defined by speed, accuracy, and visibility. Marken’s Laboratory Advantage service line is…
Pfizer settles with two Vindamax generic makers in latest development to ATTR market – analyst
By healthadmin
As Pfizer prepares to defend its patent on its transthyretin amyloid cardiomyopathy (ATTR-CM) drug tafamidis…